Your browser doesn't support javascript.
loading
Corrigendum to "Acute TNFα levels predict cognitive impairment 6-9 months after COVID-19 infection" [Psychoneuroendocrinology 153 (2023) 106104].
Nuber-Champier, A; Cionca, A; Breville, G; Voruz, P; Jacot de Alcântara, I; Allali, G; Lalive, P H; Benzakour, L; Lövblad, K-O; Braillard, O; Nehme, M; Coen, M; Serratrice, J; Reny, J-L; Pugin, J; Guessous, I; Landis, B N; Griffa, A; Van De Ville, D; Assal, F; Péron, J A.
Afiliación
  • Nuber-Champier A; Clinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, University of Geneva, Geneva, Switzerland; Neurology Division, Geneva University Hospitals, Switzerland.
  • Cionca A; Clinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, University of Geneva, Geneva, Switzerland.
  • Breville G; Neurology Division, Geneva University Hospitals, Switzerland.
  • Voruz P; Clinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, University of Geneva, Geneva, Switzerland; Neurology Division, Geneva University Hospitals, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
  • Jacot de Alcântara I; Clinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, University of Geneva, Geneva, Switzerland; Neurology Division, Geneva University Hospitals, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
  • Allali G; Leenaards Memory Center, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Lalive PH; Neurology Division, Geneva University Hospitals, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
  • Benzakour L; Faculty of Medicine, University of Geneva, Switzerland; Psychiatry Department, Geneva University Hospitals, Switzerland.
  • Lövblad KO; Faculty of Medicine, University of Geneva, Switzerland; Diagnostic and Interventional Neuroradiology Department, Geneva University Hospitals, Switzerland.
  • Braillard O; Division and Department of Primary Care Medicine, Geneva University Hospitals, Switzerland.
  • Nehme M; Division and Department of Primary Care Medicine, Geneva University Hospitals, Switzerland.
  • Coen M; Division of General Internal Medicine, Department of Medicine, Geneva University Hospitals and Geneva University, Switzerland.
  • Serratrice J; Division of General Internal Medicine, Department of Medicine, Geneva University Hospitals and Geneva University, Switzerland.
  • Reny JL; Division of General Internal Medicine, Department of Medicine, Geneva University Hospitals and Geneva University, Switzerland.
  • Pugin J; Faculty of Medicine, University of Geneva, Switzerland; Intensive Care Department, Geneva University Hospitals, Switzerland.
  • Guessous I; Faculty of Medicine, University of Geneva, Switzerland; Division and Department of Primary Care Medicine, Geneva University Hospitals, Switzerland.
  • Landis BN; Faculty of Medicine, University of Geneva, Switzerland; Rhinology-Olfactology Unit, Otorhinolaryngology Department, Geneva University Hospitals, Switzerland.
  • Griffa A; Neurology Division, Geneva University Hospitals, Switzerland; Institute of Bioengineering, Center for Neuroprosthetics, Ecole Polytechnique Federale de Lausanne (EPFL), Geneva, Switzerland.
  • Van De Ville D; Faculty of Medicine, University of Geneva, Switzerland; Institute of Bioengineering, Center for Neuroprosthetics, Ecole Polytechnique Federale de Lausanne (EPFL), Geneva, Switzerland.
  • Assal F; Neurology Division, Geneva University Hospitals, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
  • Péron JA; Clinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, University of Geneva, Geneva, Switzerland; Neurology Division, Geneva University Hospitals, Switzerland. Electronic address: julie.peron@unige.ch.
Psychoneuroendocrinology ; 155: 106324, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37380558
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Psychoneuroendocrinology Año: 2023 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Psychoneuroendocrinology Año: 2023 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido